Table 1.
Antibodies employed in the current investigation.
Antibody | Corporation | Catalog | Dilution |
---|---|---|---|
anti-GR | Santa Cruz, Dallas, TX, USA | SC1004 | 1:500 |
anti-NF-kB (p50) | Santa Cruz, Dallas, TX, USA | SC7178X | 1:5000 |
anti-phosphorylated-GR | Cell Signaling Technology, Danvers, MA, USA | 4161S | 1:500 |
anti-LDLR | Protein Group, Qingdao, China | 10785 | 1:500 |
anti-PPARG | Bioworld Technology, Shanghai, China | BS6442 | 1:500 |
anti-PGC1 | Santa Cruz, Dallas, TX, USA | SC13067 | 1:200 |
anti-PPAR-α | Bioworld Technology, Dublin, OH, USA | BS1689 | 1:500 |
anti-SCD-1 | Proteintech, Chicago, IL, USA | 28678-1-AP | 1:2000 |
anti-Lamin A/C | Bioworld Technology, Dublin, OH, USA | BS1446 | 1:500 |
anti-GAPDH | Minneapolis, Bloomington, MN, USA | AP0066 | 1:10,000 |